Clinical Trial Update: Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab for Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety, tolerability, and efficacy of doxorubicin in combination with pembrolizumab for soft tissue sarcoma has completed with posted r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Soft Tissue Sarcoma, Adult, Soft Tissue Sarcoma, Child | Phase 2 | Status: COMPLETED | Results posted: 2023-02-08